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INTRODUCTION 
Since 20th century, there were many reports of spiral organisms 
being isolated from the stomach of human beings and the possible role of 
these organisms in any human gastric disease. It was culmination of many 
years of effort by J. Robin Warren and Barry J. Marshall in Perth, 
Australia. With the isolation of H.pylori, the flood gates opened to a new 
understanding of gastro duodenal pathology and its implications in the 
management of peptic ulcer disease.1 
It is a bacterial pathogen infecting the gastric antrum of half the 
population worldwide. Helicobacter pylori(H.pylori) infection has found 
to be associated with acute and chronic gastritis,non-ulcer dyspepsia, 
peptic ulcers, gastric adenocarcinoma and gastric MALT associated 
lymphomas.2 
Colonization of stomach by H.pylori and chronic active gastritis 
has a cause and effect relationship. Early detection and eradication of 
H.pylori infection is very essential because it not only cause healing of 
gastric inflammatory lesion but also helps in reversal of precursor lesion 
which results in carcinoma such as gastric atrophy and intestinal 
metaplasia. 3 
The Sydney system for the classification of gastritis emphasises the 
importance of topographical, morphological and etiological information. 
This system was revised at the Houston Gastritis Workshop held in 1994.  
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The histological severity of H.pylori density, inflammation, 
activity, atrophy and intestinal metaplasia were graded according to the 
updated Sydney system.4 
Endoscopic biopsy allows detection of H.pylori, which determines 
treatment for peptic ulcer disease. 
For most studies histology is the standard for detection, because the 
objective is determination of whether the organisms are present and 
whether there is gastritis. 
The epithelial changes in H.pylori colonized gastric mucosa can be 
recongnised with routine H&E sections and it helps as a indicator to 
notify the presence H.pylori in gastric mucosa . 
As effective specific treatment for H.pylori associated 
gastroduodenal disorders is already in vogue,the identification of the 
organism has become mandatory in antral biopsies.  
The present study was planned to analyse the spectrum of the light 
microscopic histopathologic changes in gastric mucosa colonized by 
H.pylori in patients presenting to the outpatient department of medical 
gastroenterology. 
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AIMS AND OBJECTIVES 
1. To evaluate the spectrum of light microscopic histopathological 
changes in gastric mucosa in patient with active chronic gastritis.  
2. To detect the H.pylori organism using Light green stain and compare 
the staining qualities with that of Warthin – Starry Silver stain. 
3. To correlate the bacterial load with the histomorphological changes. 
4. To analyse the histomorphological changes of esophagus in the same 
cases. 
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REVIEW OF LITERATURE 
EMBRYOLOGY OF STOMACH: 
The embryonal stomach is derived from the primitive foregut. At 
the end of 5th gestational week, the embryonal stomach undergoes a 90 
degree rotation around its longitudinal axis, so that left side faces forward 
and the right side faces toward the back.This determines that the left 
vagus nerve is located anteriorly in postnatal life whereas the right vagus 
nerve innervates mostly the posterior aspect of the stomach. At the time 
of such rotation, the posterior wall grows more rapidly than the anterior, 
thus giving rise to major and lesser curvatures.5 
In the early stages, the stomach is situated in the midline. However, 
later on, the caudal portion is mobilized upward and to the right, 
constituting the antropyloric portion.The cephalic portion, on the other 
hand, rotates toward the left and slightly downward, becoming cardia.5 
ANATOMY AND HISTOLOGY: 
Anatomically, stomach is divided into four regions: the cardia, 
fundus, body(corpus) and pylorus (pyloric antrum). Cardia is a small area 
of mucus secreting glands surrounding the entrance of the oesophagus. It 
measures only a few millimetres or may be incomplete or absent 
altogether.6 
Mucosa of the fundus and body of the stomach consists of straight 
tubular glands that extend upto level of muscularis mucosa and gastric 
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pits that occupy about one quarter thickness of the gastric mucosa and has 
gastric glands opening into it. The gastric glands contain a mixed 
population of cells, surface mucus cells, neck mucus cells, parietal or 
oxyntic cells, chief cells (peptic or zymogenic cells), neuroendocrine cells 
and stem cells.6 
Gastric luminal surface and part of the gastric pits are covered by 
surface mucus cells .Neck mucus cells are seen between the parietal cells 
in the neck and base of the gastric glands. Parietal cells are distributed 
along the length of the glands and they are identified with following 
histological features showing large round cells having dense eosinophilic 
cytoplasm with centrally placed nucleus whereas Peptic cells are 
recognised by their dense basophilic cytoplasm with condensed basally 
located nucleus. Neuroendocrine cells are found in the base of the gastric 
glands. Stem cells are found in the neck of gastric glands whereas Lamina 
propria is loose vascular and scanty.6 
The submucosa is also loose like that of lamina propria but it is 
distensible and contains large blood vessels. Muscularis propria 
composed of two layers inner circular and outer longitudinal layers. The 
serosal layer, which covers the peritoneal surface, is thin.6 
Pyloric glands are branched and coiled and gastric pits occupy 
about half the thickness of the pyloric mucosa. The glands are lined 
almost exclusively by mucus secreting cells, a small number of parietal 
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cells and neuroendocrine cells that secrete gastrin and thus are called G 
cells.6 
HELICOBACTER PYLORI –HISTORICAL PERSPECTIVE : 
Marshall BJ et al (1984) imprinted in his study that, for the past 45 
years spiral bacteria in stomach have been repeatedly observed, reported 
and forgotted.  In 1890s, Bizzozero described the spiral bacteria in dogs.7 
Dooley CP mentioned in his study that early review shows the 
presence of spiral shape organism in the stomachs of dogs in 1893. It was 
also reported in rats and cats in 1896. Autopsy study by Doenges in 1938 
found the prevalence rate of 43% for spiral organisms in the human 
stomach, but unfortunately he did not detect a relation between the 
presence of the organism with its relation to various gastric diseases.8 
1906 Cheng ML et al in their study mentioned that in gastric spiral 
organisms was identified in vomitus from a patient with gastric 
carcinoma.9 
Marshall BJ et al in 1940,mention that  Freedburg and Baron stated 
that “spirochetes” could be found in up to 37% of gastrectomy specimens, 
but examination of gastric suction biopsy material failed to confirm this 
finding.10 
Buckley MJM et al in their study mentioned that in 1950, 
Fitzgerald and Murphy Studied about urease in the resected stomachs of 
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patients with gastric ulceration. In 1968, the bacterial source of gastric 
urease was confirmed.11 
Marshall BJ et al  mentioned in his study  in 1975 that spiral 
bacteria have strong association with gastritis about 80% and he studied 
this in gastric resected specimens from patients with gastric 
ulceration.This spiral bacilli were said to be Pseudomonas at first, 
possibly a contaminant and the bacteria were forgotten again.10 
Buckely MJM et al in their study mentioned that in 1979, spiral 
bacteria were observed in the luminal surface of epithelial cells of gastric 
ulcer patients. 
Hellstrom PM et al in their study mentioned that in 1982, 
Australian doctors Barry J. Marshall and J. Robin Warren discovered the 
bacteria and found that the appearance of this bacteria was similar to that 
of Campylobacter genus and primarily named the bacteria as  
Campylobacter pyloridis.11 
BACTERIOLOGY: 
The organism shares the features of  Campylobacter organism such 
as micro-aerobic, curved, gram-negative ,so they were named as 
Campylobacter pyloridis initially. Later they found that it is a motile 
bacillus with multiple polar flagella and they distinguish it from other 
campylobacter species by its surface proteins, the unusual fatty acids that 
compose its cell wall and its deoxyribonucleic acid (DNA) composition.12 
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Goodwin CS et al (1993) and Windsor HM et al (2000) in their 
study mention that the new name Helicobacter was published in October 
1989 (Helico = curved, bacter =staff). According to Kusters JG et al, in 
1989, a new genus name was suggested ‘Helicobacter’ reflects the two 
morphological appearances of the organism, helical in vivo but often rod 
like in vitro and that this organism is distinct from members of the genus 
Campylobacter.13 
H.pylori organism have following characteristic features for their 
identification they are tiny spiral form organism measuring 1 to 3 microns 
in length and 0.3 to 0.6 microns in width with unipolar, multiflagellate. 
Under unsuitable environment the spiral shape H.pylori organism will 
undergo transformation into coccoid forms and this Coccoid forms 
measures range from 0.4 to 1.2 microns in diameter and ultrastructurally 
appear as U shaped bacilli with ends joined by a membranous structure. 
H.pylori usually present in surface of the gastric mucosal lining or 
sometimes within the epithelium or within the lumen of the gland. In 
haematoxylin and eosin (H&E) stained section it appears as faintly 
eosinophilic organisms. Sometimes it is difficult to identify the H.pylori 
organism because it is easily masked by abaundant mucus, cellular 
membranes of gastric epithelial cells and contaminating oropharyngeal 
mucosa or other foreign material introduced by the endoscope. H. pylori 
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are microaerophilic, growing best in an atmosphere of 5% oxygen with 5-
10% CO on the blood containing media.14 
Its helicoidal shape and high motility due to action of multiple 
flagella allow it to cross the thick layer of mucus and stay beneath it, 
thereby making the successful colonization of the human stomach 
possible, where gastric acidity and peristalsis normally inhibit bacterial 
coloniszation.15 
RESERVOIR OF H.PYLORI INFECTION: 
Human stomach is the natural reservoir of the H.pylori infection. 
But it may also detected in the laboratory animals such as monkeys and 
cats when they are infected with H.pylori organism.The  DNA of H.pylori 
were found to be present in 60% milk samples and 3% sheep tissue 
samples. 16 
Intestinal tract of house flies may harbour H.pylori infection but 
there is  no evidence of transmission to human from them were detected 
till date.17 
SURVIVAL OF H.PYLORI IN THE STOMACH: 
Eaton and Krakowa mention that urease is essential for the survival 
of H.pylori in the acidic environment .Thus for initiation of infection 
urease must be neeed.H.pylori make fit to reside in the acidic medium by 
means of splitting urea by secreating large amount of urease into the 
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microenvironment .Compare to other bacteria ,H.pylori has urease in their 
intact cell membrane but other bacteria will have it in the cytoplasm.18 
Normally H.pylori has its urease in the cytoplasm but they may be 
actively adsorbed into the cell membrane . The presence of 
supramolecular structure in Urease enzyme make the H.pylori to survive 
in acidic environment. H.pylori urease has both alpha and beta subunit 
along with internal cavity which is filled by tissue fluid but it will be 
filled by urease during the time of requirement.19 
INCIDENCE AND TRANSMISSION: 
H.pylori infections occur worldwide, although there are marked 
geographic variations in their incidence. The prevalence of H.pylori 
infections in adults ranges from <15% in some populations to virtually 
100% in less well-developed areas. There are also substantial variations 
among different ethnic groups in the same geographic locale. Because of 
the low socioeconomic condition H.pylori infection affects the people 
earlier in developing countries than the developed countries of the world, 
so thereby prevalence of H.pylori infections correlates well with lower 
socioeconomic status.20 The human stomach is the primary reservoir for 
the organism and it is transmitted via an oral route and possibly via a 
gastric oral and faeco oral route .21 The infection is easily passed from 
one family member to another, particularly in areas of dense housing. 
Children under the age of 5 are most susceptible to H.pylori infections. 
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H.pylori infections are present in gastric biopsies of 16.8% to 55% of 
children with abdominal pain, upper gastrointestinal symptoms and 
histologic evidence of acute and chronic gastritis.20The infection 
prevalence in developing countries can be as high as 75% by age 25. 
There has been a recent decline in the incidence of H.pylori 
infections in the developed world, largely due to improved living 
conditions and a decrease in living density and family size. Even though 
the prevalence of H.pylori infections is currently decreasing, at least 50% 
of the world population is infected with the organism.22 
Recurrent infections are usually a persistent infection rather than 
the acquisition of new infections. Infection with more than one H.pylori 
strain can also occur.  
When AIDS patients become infected, the disease may exhibit 
particularly virulent characteristics and large numbers of organisms may 
be present. 
PATHOGENESIS: 
H.pylori is highly adapted to occupy a special ecologic gastric 
niche with unique features that allow it to enter the mucus of the mucosal 
barrier, attach to the epithelium, evade immune responses, proliferate and 
colonize the gastric mucosa. The eventual outcome of H.pylori infections 
reflects strain-specific, environmental and host-related factors. After they 
are ingested, organisms must evade the bactericidal activity of the gastric 
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lumen and enter the mucous layer. Corkscrew like bacterial movement 
and enzyme production (particularly urease and lipase) are important 
early in the infection.Bacterial proteases digest gastric mucin facilitating 
bacterial movement and urease protects the H.pylori from the luminal 
acid by creating an alkaline microenvironment around the bacterium.23,24 
H.pylori bacteria normally reside in the unstirred layer of gastric 
mucus. They wind down to the epithelial surface, moving easily through 
the viscous environment above it, to attach themselves to the apical 
membranes of foveolar cells . Bacterial adhesins recognize cell surface 
specific proteins facilitating epithelial colonization. The best 
characterized adhesin, BabA, is a 78-kD outer bacterial membrane 
protein that binds to the fucosylated Lewis B blood group antigen.25 The 
Lewis blood group terminal carbohydrate structures are present on the 
ends of MUC1 carbohydrate side chains as well as on secreted mucins. 
MUC1 is highly polymorphic and evidence suggests that functional 
allelic differences affect infection susceptibility.26H.pylori bacteria also 
bind to MUC5AC, a major mucin produced by foveolar cells. Bacteria 
unable to adhere to the epithelium are rapidly cleared from the mucosa. 
H.pylori bacteria preferentially attach at or near intercellular junctions, 
penetrating the junctional complexes moving down along the lateral cell 
membranes. This disrupts intercellular tight junctions between viable 
cells, allowing luminal contents, including acid, to flow between the cells. 
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Most H.pylori strains secrete the vacuolating cytotoxin (VacA).  
This toxin inserts itself into the epithelial cell membrane and forms a 
hexameric anion-selective, voltage-dependent channel through which 
bicarbonate and organic anions can be released, possibly providing 
H.pylori bacteria with their nutrients. 27VacA also inhibits T-lymphocyte 
activation. Most H.pylori bacteria possess the cag pathogenicity island 
(cag PAI) that contains 29 distinct genes.  Some of these genes facilitate 
translocation of the CagA protein into foveolar cells.28 Once in the cells, 
CagA is phosphorylated and binds to the SHP-2 tyrosine 
phosphatase,leading to host growth factor like cellular responses, 
cytokine production and cell proliferation.29 These cytokines mobilize 
leukocytes to areas of immune challenge . CagA also plays a major role 
in disruption of the apical junctional complexes. CagA-positive strains 
associate with increased epithelial cell apoptosis.30 
The oipA (outer inflammatory protein) gene encodes one of the 
outer membrane proteins and is an inflammation-related gene near, but 
not in, the CagA PAI. oipA functional status correlates with clinical 
presentation, H.pylori density and gastric inflammation. OipA and the cag 
PAI are both necessary for full activation of the IL-8 promoter.Nitric 
oxidase synthase and cyclooxygenase-2 are induced by H.pylori 
infections; these enzymes modulate the inflammatory responses.31 
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HOST RESPONSES TO HELICOBACTER PYLORI : 
H.pylori infections cause gastric inflammation (gastritis) in almost 
all infected persons, although the severity of the changes varies among 
individuals. The injury results from both the infection and its associated 
inflammation. Bile reflux and dietary irritants may further enhance the 
deleterious bacterial effects. Additionally, anti-H.pylori antibodies that 
cross-react with the gastric mucosa induce further damage. Some 
H.pylori infected patients develop an autoantibody response directed at 
the H+-K+-ATPase pump in parietal cells leading to atrophy of the 
corpus.32 
Initially neutrophils are recruited to the infected site, followed by 
the recruitment of T and B lymphocytes, plasma cells and macrophages. 
The neutrophilic infiltrate and mononuclear phagocytic activation may be 
facilitated by bacterial urease production and induction of nitric oxide 
synthase and cyclooxygenase.33 H pylori infections generate significant 
cellular and humoral responses via antigenic stimulation of mucosal 
monocytes and T cells. The inflammatory cells produce numerous 
cytokines (TNF, interferon and interleukins 1, 6 and 8), prostaglandins, 
proteases and reactive oxygen metabolites that cause epithelial necrosis 
and mucosal injury. IL-8, a potent neutrophil-activating chemokine 
expressed by gastric epithelium, plays a central role in the inflammatory 
response.34 H pylori bacteria containing the cag PAI induce a stronger IL-
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8 response than cag-negative strains. Some cytokines promote leukocyte 
adhesion to endothelial cells and others recruit additional leukocytes to 
the infected site. Mediators of local humoral responses, such as mucosal 
IgA, attract eosinophils, which then degranulate. Stimulated B cells 
differentiate into IgM, IgA and IgG antibody producing cells.35 IgA 
promotes complement-dependent phagocytosis and H.pylori killing by 
polymorphonuclear neutrophils (PMNs). Secretory IgA synergizes with 
IgG to promote antibody-dependent cell-mediated cytotoxicity induced 
by PMNs, monocytes and lymphocytes. High anti- H.pylori IgG antibody 
levels correlate with severe antral gastritis and dense H.pylori antral 
colonization.36 
H.pylori infections result in hyposecretion, hypersecretion or 
normal acid secretion, depending on disease stage. Hypochlorhydria 
develops when the gastritis extends proximally to involve and destroy the 
oxyntic mucosa. Acid secretion increases via several mechanisms.37 
Patients with an increased parietal cell mass and hyperchlorhydria exhibit 
antral restriction of the gastritis because the high acid levels protect the 
corpus from bacterial adhesion and inflammation. 
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SIGNS AND SYMPTOMS: 
H.pylori infected person at early period doesn’t show any 
symptoms .During acute infection patient develops abdominal pain and 
nausea. Later during chroninc gastritis patient develops abdominal pain, 
nausea, bloating, blenching and vomiting. H.pylori related inflammation 
in gastric antral mucosa results in duodenal ulcers whereas inflammation 
in corpus results in gastric ulcer and gastric carcinoma.38 
HISTOMORPHOLOGICAL CHANGES IN H PYLORI INFECTED 
GASTRIC MUCOSA : 
1.NEUTROPHIL INFILTRATION 
Infiltration of neutrophils in lamina propria of the stomach 
indicates the active component of gastritis which indicates the release of 
inflammatory mediators in sustained manner. Detection of  neutrophil 
infiltration  helps in differentiation of various types of gastritis. Abundant 
infiltration of neutrophils in lamina propria were seen in acute phase of 
infections e.g., phlegmonous gastritis. Moderate to severe infiltration of 
neutrophils were seen in active phase of Helicobacter-induced gastritis, 
whereas minimal infiltration of neutrophils in lamina propria is seen in 
acute hemorrhagic gastritis  secondary  to chronic alcoholism and use of  
nonsteroidal antiinflammatory drug.39 
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2.MONONUCLEAR INFILTRATION 
Mononuclear infiltrates such as lymphocytes and plasma cells were 
normally seen in antral mucosa as few numbers but it is completely 
absent in corpus of the stomach. It is advised to diagnose gastritis in the 
presence of five or more clusters of mononuclear cells in the lamina 
propria or else as a diffuse infiltrate. 
Infiltration of lymphocytes , plasma cells and mast cells will not be 
seen normally in gastric mucosa but their presence under abnormal 
condition strongly suggest that chronic H.pylori gastritis but in 
autoimmune gastritis, the infiltrate is diffuse, predominantly plasma cells 
and lymphocytes were seen in mucosa and submucosal layers.39 
3. LYMPHOID AGGREGATES AND FOLLICLES 
In stomach small lymphoid aggregates were seen in corpus near 
muscularis propria or else at the base of the lamina propria. But in 
pathological condition such as H.pylori gastritis, large lymphoid 
aggregates with germinal centers were observed. It indicates the presence 
of H.pylori in gastric mucosa. In endoscopy presence of multiple 
nodularity indicates presence of lymphoid follicles which indicates 
H.pylori induced follicular gastritis.40 
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4. EOSINOPHIL INFILTRATION 
In normal person only scattered eosinophils were be identified in 
lamina propria of gastric mucosa. But in case of H.pylori gastritis few 
eosnophilic infiltrates will be present along with plasma cells and 
lymphocytes .Compare to adults, childrens have modereate to severe 
eosinophilic infiltrtate in H.pylori gastritis.41 
5. MUCOSAL HYPEREMIA AND EDEMA 
Endoscopically mucosal hyperemia and edema indicates the 
presence of H.pylori gastritis which is due presence mast cells 
abaundantly in gastric mucosa but it may also be seen in chemical 
induced gastritis .42 
6. SURFACE EPITHELIUM DEGENERATION 
Any injury to gastric mucosa will results in surface epithelium 
degeneration which may results in gastritis. Surface epithelial injury is 
mainly due to chemical injury caused due to bile reflux, ethanol etc. and 
also due to H.pylori. This surface epithelial Degeneration may leads to 
change in columnar epithelium into cuboidal epithelium along with 
depletion of mucin. This findings were seen even when the H.pylori in 
few numbers in gastric mucosa. In epithelial regeneration the epithelial 
cells arranged in one over the other in piling up fashion at the surface of 
the gastric mucosa which is a well known feature of H.pylori associated 
gastritis.43 
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7. SURFACE EROSION 
Severe epithelial injury and necrosis of gastric mucosa leads to 
Surface erosions. Surface erosion usually confined to muscularis 
mucosae. Endoscopically H.pylori associated surface erosion will be 
elevated from the surface of the mucosa. The erosion usually filled with 
fibrinoid necrosis containing neutrophils and cellular debris and 
surrounding margin show hyperplastic and regenerative changes of the 
epithelium.44 
8. FOVEOLAR (“PIT”) HYPERPLASIA 
 Increase exfoliation of surface epithelium of gastric mucosa will 
occur in H.pylori associated gastritis .In order to compensate the loss , 
gasrtric pit epithelial cell get proliferated which leads to elongation and 
tortuosity of the gastric pit which atlast result in Foveolar hyperplasia. 
Other important findings of foveolar hyperplasia include the presence 
cuboidal epithelial cells having hyperchromatic nuclei with increase 
nuclear cytoplasmic ratio along with features of upper pit mitoses and 
mucin depletion.45 
9. INTESTINAL METAPLASIA 
Gastric intestinal metaplasia (IM) is quite common. It is believed to 
represent a response to chronic injury, often caused by H.pylori 
infections. Intestinal metaplasia  has been implicated in the development 
of both gastric and esophageal carcinoma. Intestinal metaplasia usually 
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starts at junction between the antrum and corpus in a patchy and 
multifocal fashion after that it spread both proximally and distally to 
involve the entire antrum and fundus of the stomach. The areas of 
Intestinal metaplasia increase with patient age and often become 
confluent, replacing large areas of the gastric mucosa. Intestinal 
metaplasia more frequently coexists with gastric cancer than with gastric 
ulcer, but it shows the same distribution when associated with either 
condition. 
In Intestinal metaplasia the cells that normally line the gastric 
mucosa (surface epithelium, foveolar epithelium and glands) are replaced 
by an epithelium resembling that of the small or large intestine. The 
earliest metaplastic changes consist of the appearance of mucin-negative 
absorptive enterocytes with a brush border alternating with Alcian blue 
positive goblet cells. In young individuals with less extensive IM, the 
metaplastic glands resemble normal small intestinal epithelium. Initially, 
only the epithelial type changes, but later the mucosal architecture 
acquires a small intestinal villiform architecture, often containing Paneth 
cells at the base of the pits. Paneth cells in areas of IM do not have the 
same uniform distribution seen in the intestine. In some cases, they are 
limited to the antral corpus border and are lacking in IM in the distal 
stomach. They may lie in the superficial portions of the metaplastic 
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gland; ultrastructurally some Paneth cells contain both Paneth cell 
granules and mucinous vacuoles . 
Goblet cells are easily seen on H&E-stained sections. However, an 
Alcian blue/PAS stain is commonly used to identify the goblet cells since 
it stains all acidic mucins blue-purple and neutral mucins magenta and is 
easy to perform and interpret. These cells have a complete switch in their 
differentiation program from a gastric to an intestinal phenotype and they 
have been termed small intestinal, complete, or type I Intestinal 
metaplasia.46 
10. ATROPHY 
Loss of gastric glands leads to atrophy. If there is any injury to 
gastric mucosa with whatever the etiology may be, it undergo 
regeneration into normal epithelium or it may leads to change over of 
native glands into metaplastic glands. 
When injured glands fail to undergo regeneration ,the lamia propria 
will be replased by extracellular matrix and fibroblast which results in 
loss of function of the gastric epithelium and it is termed as atrophy.The 
adjacent gastric glands will undergo pyloric metaplasia or intestinal 
metaplasia. Pyloric metaplasia is named because metaplastic glands 
resembles to that of normal pyloric glands and intestinal metaplasia is 
named because the glands have absorptive intestinal epithelial lining with 
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goblet cells. In autoimmune gastiritis immune mediated destruction 
occurs in the fundic gland epithelium which result in atrophy.47 
RELATIONSHIP OF HELICOBACTER PYLORI TO GASTRIC 
DISEASES: 
H.pylori organism plays a significant role in the genesis of several 
gastric diseases. Patient outcomes reflect differences in host 
susceptibility, organism virulence or both. The development of gastritis, 
ulcer and gastric cancer all involve an interplay between environmental, 
host, genetic and microbial factors.48 
HELICOBACTER PYLORI RELATED DISEASES 
The following are some of the H pylori associated gastric disease 
entities48 
 Acute gastritis 
 Chronic gastritis 
 Chronic active gastritis 
 Follicular gastritis 
 Atrophic gastritis 
 Lymphocytic gastritis  
 Granulomatous gastritis 
 Gastric duodenal ulcer 
 Autoimmune gastritis 
 Hyperplastic polyp 
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 Intestinal metaplasia  
 G-cell hyperplasia 
 Gastric adenocarcinoma 
 Gastric Lymphoma(MALT) 
 Menetrier disease 
H.PYLORI RELATED GASTRITIS : 
H.pylori bacteria preferentially colonize the antrum, but they may 
infect any part of the stomach where they cause gastritis. When treated, 
the bacteria migrate from the antrum to the corpus with decreasing 
activity of the antral gastritis. Infections with vacA-positive H.pylori 
strains result in acute gastritis with cytoplasmic swelling and 
vacuolization, other changes were includes micropapillary changes, 
mucin loss, erosion of the juxtaluminal cytoplasm and desquamation of 
surface foveolar cells. Regenerating cells form a multicellular layer with 
indistinct intercellular borders, creating syncytial polypoid excrescences . 
Marked neutrophilic infiltrates appear in the mucous neck region  and 
lamina propria in early acute gastritis; when severe, they aggregate in the 
pit lumens to form pit abscesses. The mucosa is elevated or expanded 
slightly due to the lymphoplasmacytic cell infiltrate in the superficial 
lamina propria. At this point the lesion can be termed chronic active 
gastritis or active chronic gastritis. Eosinophils may also be present. The 
regenerative pit bases are characterized by mucin loss, cytoplasmic 
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basophilia, increased mitoses and hyperchromatic nuclei  that are 
sometimes severe enough to mimic dysplasia. If the pits and glands 
appear parallel to one another with intervening lamina propria, in that 
occasion pathologist should think twice before making a diagnosis of 
carcinoma, even in the presence of severe glandular or cellular atypia. 
Both the neutrophils and the bacteria destroy the epithelium, 
causing the mucous neck cells to proliferate in an effort to replace the 
dying cells. Other changes in severe infections include epithelial cell 
dropout, microerosions, larger erosions and ulcers. Erosions forming in 
the setting of H.pylori infections typically lack the homogeneous 
eosinophilic necrosis seen in patients with stress ulcers or aspirin or 
NSAID related ulcers. The acute foveolitis may associate with an 
epithelial alteration known as the (clear) cell change. Malgun cells have 
enlarged euchromatic nuclei, abundant cytoplasm and increased 
expression of proliferating cell nuclear antigen (PCNA) and cytokeratin 
8, indicating that they are mitotically and metabolically active. Malgun 
cells may be morphologic indicators of genomic damage and repair.49 
H.pylori eradication causes rapid neutrophil disappearance. 
Eosinophils disappear more slowly. The surface changes reverse rapidly 
and the epithelial cells acquire their normal shape and spatial organization 
within a few days of H.pylori eradication. However, any atrophy that had 
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developed remains, as do the lymphoid aggregates. These features 
become a permanent component of the once-infected gastric mucosa. 
In quiescent superficial gastritis, the acute inflammation, edema 
and vascular congestion disappear and the epithelium returns to normal. 
However, the lamina propria contains increased numbers of mononuclear 
cells. Chronic superficial gastritis progresses to the next stage, chronic 
atrophic gastritis, over a period of 15 to 20 years.50Since chronic gastritis 
develops as a patchy process, all stages in the evolution of chronic 
gastritis often coexist in a single stomach leading to the term multifocal 
atrophic gastritis.  
Lymphoid aggregates appear and sometimes lymphoid follicles 
develop. These are located deep in the mucosa, near the muscularis 
mucosae. When lymphoid follicles develop, with or without follicular 
centers, the lesion is termed follicular gastritis.51 Antral lymphoid 
follicles can become quite prominent, sometimes causing mucosal 
nodularity, especially in children.52 The lymphoid aggregates represent an 
immune response to the bacteria. Their presence provides a useful marker 
for H.pylori infections. Their number may decrease when the H.pylori 
infections are treated.  
Granulomatous gastritis develops in approximately 1% of H.pylori 
infected patients, usually in patients with small numbers of organisms. 
The granulomas develop late in the disease, after the host has become 
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sensitized to the organism. Antibody-coated bacteria ingested by 
macrophages may stimulate a histiocytic response .53 
Diffuse antral gastritis (DAG) is often considered to represent part 
of the peptic ulcer disease spectrum with antral and duodenal ulcers since 
it associates with increased gastrin, acid and pepsin secretion.54The 
hyperacidity creates a hostile environment for H.pylori bacteria, 
restricting them to the antrum. The gastritis is characterized by an intense 
antral mononuclear infiltrate consisting of mature lymphocytes and 
plasma cells. Follicular gastritis is common. The epithelium may appear 
mucin depleted and there may be pit elongation. 
Occasionally H.pylori infections lead to the development of 
enlarged gastric folds in the gastric body, creating an endoscopic pattern 
suggestive of a hypertrophic gastritis/ gastropathy.55 The H.pylori 
induced mucosal fold thickening is termed giant fold gastritis. This 
differs from Menetrier disease  in that the mucosa is thinner in giant fold 
gastritis and there is less foveolar hyperplasia.56 
SYDNEY SYSTEM: 
In view of avoiding the diagnostic confusion in gastritis. In 1990 a 
workshop was conducted in World Congress of Gastroenterology in 
Sydney to establish guidelines for a new classification of gastritis based 
on a grading system called the "Sydney System". In 1994 it was modified 
at the workshop held at the Houston.  
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The Sydney System of grading and classification of gastritis is 
introduced in aim of producing a standardized approach to the 
histological interpretation of gastric biopsies. Its importance lies to 
provide a universal language among the pathologist to give diagnosis. 
Sydney system has evolved a new classification of gastritis which is 
simple,comprehensive and easy to apply(Fig.A).57 
Sydney system consists of two divisions 
1. Histological 
2. Endoscopic 
The backbone of Histological division is topographical distribution 
of abnormalities of gastric antrum alone, gastric corpus alone, or both 
pangastritis. 
Histological division of Sydney system consists of three parts: 
• Aetiological (prefix) 
• Topography (Core) 
• Morphology (Suffix) 
Morphologically, the Sydney system recognizes only three types: 
1. Acute gastritis 
2. Chronic 
3. Special forms 
Variables in morphological aspect pertinent to chronic gastritis are 
as follows: 
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Normal mucosa:  
Contains scattered mononuclear cells, lymphocytes and plasma 
cells with occasional lymphocyte aggregates in the corpus, no 
granulocytes. 
Acute / Chronic:  
Acute gastritis, if neutrophils are dominant. Chronic gastritis if 
mononuclear inflammatory cells are dominant. 
Inflammation:  
Refers to presence of inflammatory cells in lamina propria, 
distribution of which is disregarded in this classification. 
Atrophy:  
Refers to loss of gastric glands. Old classification as chronic 
atrophic gastritis is disregarded and inflammation and atrophy are 
assessed independently. 
Activity:  
Refers to presence of neutrophilic granulocytes in the lamina 
propria, in intraepithelial sites or both. 
Intestinal metaplasia:  
Individual pattern of intestinal metaplasia are classified as type i, ii 
and iii may be commented on, but are not graded. 
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Helicobacter pylori:  
Presence of Helicobacter pylori is commented upon using a simple 
stain and not a silver stain.58 
REVISED SYDNEY CLASSIFICATION 59 
1. Based on site  
Antrum, Body& other 
2. H pylori:  
It is graded as absent when there is no H.pylori were detected in 
gastric mucosa, in case of mild grade one  to three bacteria in pits or on 
the mucosal surface should be noted , moderate means presence of 
organism with a layer of bacteria or marked means presence of organism 
as clumps. 
3. Chronic inflammation:  
Usually in normal person few number of lymphocytes and 
histiocytes were present in the lamina propria of gastric mucosa, in case 
of mild inflammation there should be presence of ten cells more than 
normal in high power field, in moderate inflammation presence of  eleven 
to twenty cells more than normal and marked inflammation should have 
twenty cells more than normal. 
4. Acute inflammation:  
If there is no neutophils in the lamina propria it is termed as 
normal, presence of 5 neutrophils fall under mild acute inflammation, 
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presence of 5 to 10 neutrophils comes under moderate and presence of 
more than 11 neutrophils in the lamina propria along with pit abscess 
comes under severe acute inflammation. 
 5. Atrophy:  
Loss of glands termed as atrophy and it is graded as absent, mild, 
moderate and marked according to the visualanalog scales. 
6. Intestinal metaplasia:  
It has two types the first one is incomplete metaplasia in which the 
gastric glands are replaced into metaplastic glands which shows presence 
of goblet cells, brush bordercells and Paneth cells and graded as absent, 
mild, moderate and marked according to the visual –analog scale. 
In Incomplete intestinal metaplasia the glands shows the presence of 
colonic mucosa and goblet mucous cells. Complete intestinal metaplasia 
resembles small intestine and they shows presence of absorptive brush 
border cells as well as Paneth and goblet cells. 59 
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SYDNEY SYSTEM OF GRADING AND CLASSIFICATION OF 
GASTRITIS(Fig:A) 
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NON ULCER DYSPEPSIA: 
One of the most common gastrointestinal problem encountered by 
clinician is Non ulcer dyspepsia (NUD). Non ulcer dyspepsia is defined 
as complex symptoms in the upper gastrointestinal tract that present for 4 
weeks without any structural and biochemical alteration. The Rome 
consensus committee held in 1991 were establish Diagnostic criteria and 
later it was updated in 1998 in Vienna. Non ulcer dyspepsia usually 
present with multifactorial etiology, thereby different mechanisms result 
in different subtypes of disease, which have been subgrouped on the basis 
of the predominant symptom type – ulcer like, reflux like and dysmotility 
like. 
Non ulcer dyspepsia were more commonly infected with H.pylori 
organism compared to the gastritis or peptic ulcer disease patient. Non 
ulcer dyspepsia patient were more prone for H.pylori infection When 
compared to asymptomatic person .56 
According to Rosenstock S et al (1997), studies certain symptoms 
of non ulcer dyspepsia such as bloating and belching give a clue clinically 
for the presence of H.pylori in the gastric mucosa.57 
Tally NJ (1999) mention that 40-90 present of the patient with non 
ulcer dyspepsia bear H.pylori infection.58 
Varasa TA et al (2008) observed a that early detection and 
eradication therapy of H.pylori gives more benefit for those patient with 
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non ulcer dyspepsia when compared to symptomatic treatment . He also 
founded in his study, among 77 non ulcer dyspeptic patients,50 had H 
pylori infection(64.9%).59 
Gwee KA et al (2009) showed when compared studies conducted 
in western population, Indian studies states that asian group of people 
have greater relief from  non ulcer dyspepsia symptoms after complete 
eradication of H.pylori.60 
Abdulla M et al (2009) defines dyspepsia as epigastric pain or 
discomfort perceived to originate in the upper gastrointestinal tract, 
including heartburn, acid regurgitation, excessive belching, abdominal 
bloating, nausea, a perception of abnormal or slow digestion and early 
satiety.61 
PEPTIC ULCER DISEASE: 
H.pylori is the major cause of peptic ulcer and it usually occurs in 
middle age to older person.It has been detected in the stomach of more 
than 90% of gastric ulcer patients who were not in non steroidal anti-
inflammatory drug users. Normally peptic ulcer may heal without any 
active intervention therapy but in presence of H.pylori organism the 
recurrence of petic ulcer is very common. So active Eradication of 
H.pylori in these patients facilitates the cure of peptic ulcer and 
essentially prevents its recurrence. The epidemiology of gastric ulcer is 
immediately related to that of H.pylori infection, gastritis and gastric 
34 
 
cancer. Studies from various literature in the world shows that prevelance 
of gastritis is equal to that of H.pylori prevelance.  
Kolts BE et al (1993) states that by complete eradication of 
H.pylori from gastric mucosa helps in curing of peptic ulcer disease and 
thereby decrease overall prevalence of H.pylori induced peptic ulcer 
disease .62 
Vac A(vacuolating cytotoxin) pathologic gene product plays a vital 
role in the development of peptic ulcer disease .In a study by Zhang C et 
al (2005) of 286 patient, H.pylori induced gastric ulcer is severe than that 
of chronic gastritis and also mention that in H.pylori induced gastritis the 
severity of inflammation is more and there will be diffuse infiltration of 
inflammatory cells in lamina proria  such as neutrophils,eosinophils 
,plasma cells which results in severe mucosal inflammation and all this 
occurs because of H.pylori bacterial products which includes Urease, 
ammonia ,Vac A protein and other inflammatory mediators such as 
interleukin-8.63 
H.pylori produces various enzymes to safe guard itself and to 
produce the injury to the gastric mucosa. The enzymes includes urease 
which converts the gastric acidic medium into alkaline medium and 
thereby make suitable environment for its survival,other enzyme protease 
which breaks down glycoprotein in the gastric mucus and thereby 
converts the thick mucus into thin mucus and it   also secretes 
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phospholipase which produce surface epithelial cell injury.In addition 
H.pylori also release enzyme lipopolysaccharide which recruit 
inflammatory cells into the gastric mucosa and this inflamed mucosa is 
more prone for acidic injury. Atlast  H.pylori attracted neutrophils 
secretes myeloperoxides which produces hypochlorous acid and it is 
converted into monochloramine which cause severe damage to gastric 
epithelial cells and lamina propria endothelial cells. 
Coming to the gross and morphological changes induced by 
H.pylori in peptic ulcer disease , anterior wall of duodenum is more prone 
for ulcer than posterior wall. Gastric ulcer is most commonly occur in the 
lesser curvature of the stomach. Grossly the peptic ulcer is round to oval 
with sharply punched out lesion with overhanging edges. Histologically it 
varies from active necrosis to chronic inflammation and atlast result in 
scarring . Ulcer has 3 zones the outer fibrinoid necrotic layer, middle 
inflammatory layer predominantly composed of neutrophils and deeper 
layer shows active granulation tissue which rest on collagenous scar. 
According to Konturek SJ et al (2006) mention that complete 
eradication of H. pylori prevents the increase hydrochloric acid secretion 
in gastric ulcer patient and helps in healing with prevention of ulcer 
recurrence and also prevents the H.pylori related carcinoma complication 
in future.64 
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TUMORS 
GASTRIC ADENO CARCINOMA : 
The pre neoplastic condition for the development of 
adenocarcinoma of stomach is Gastric epithelial dysplasia (GED). 
The progression from non-neoplastic to carcinoma of stomach 
involves various steps which includes glandular atrophy,intestinal 
metaplasia ,dysplasia and atlast into adenocarcinoma. For all of the above 
mention step the main culprit was H.pylori infection in the gastric 
mucosa.It plays a vital role in early stage of development of carcinoma. 
H.pylori associated chronic gastritis leads to severe injury to gastric 
mucosa which result in increase turnover of epithelial cell to compensate 
the epithelial degeneration, as a result of this compensatory mechanism 
incomplete intestinal metaplasia develops due to DNA instability which 
leads to subsequent development of intestinal type of adenocarcinoma. 
Thereby eradication of H.pylori plays an important role in various aspects 
to prevent the development of carcinoma .It helps in prevention of 
intestinal metaplasia and atrophy and thereby stops the progression of 
disease into carcinoma and it also helps in suppression of DNA damage 
and subsequent proliferation of gastric epithelium.65 
 Patients with younger age group having H.pylori infection were at 
increased risk for developing carcinoma of stomach compared to older 
ones.  
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Infection with strains of H.pylori that carry the cytotoxin associated 
antigen A (cagA) gene is associated with gastric carcinoma.66 
H.pylori as designated as class I carcinogen by World health 
organisation. This is because it produces lifelong proinflammotory 
response and therby results continous production of free radicals which 
causes damage to the DNA thereby produces multiple mutations required 
for the gastric cancer development. 
GASTRIC LYMPHOMA: 
Gastric lymphoma is strongly associated H.pylori infection and 
thereby involved in the pathogenesis of low grade lymphoma of Mucosa 
associated lymphoid tissue (MALT).67 
Genta et al (1993) reported in young patient about the closest link 
between the H.pylori infection and gastric lymphoid follicles or ‘nodular 
gastritis’. Microscopically, this nodules were composed of lymphoid 
follicles in the lamina propria.68 
The higher prevalence in antral mucosa of lymphoid follicles and 
aggregates fits well with the distribution of primary gastric lymphomas. 
The follicles are formed due to H.pylori infection which may leads to 
gastric lymphoma atlast. In case of H.pylori gastritis the lymphoid 
aggregates and lymphoid nodules are seen at the base of the antral 
mucosa.69 
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DETECTION METHODS FOR HELICOBACTER PYLORI : 
Diagnostic tests for H.pylori include microbial cultures, histologic 
or cytologic examination, rapid urease-based tests and serologic studies. 
Endoscopy dependent invasive methods include rapid urease test 
(Campylobacter-like organism test )and histology.  
Rapid urease test is otherwise known as Campylobacter-like 
organsism test .  It is consider as rapid test for the diagnosis of H.pylori 
organism . The principle of this test is based on production of urease 
enzyme by H.pylori . This test is done at the time of doing gastroscopy . 
The biopsy taken from the antrum is placed in a medium having urea .so 
the biopsy bearing the H.pylori organism secretes urease enzyme which 
convert urea into ammonia thereby PH is raised and the colour of the 
specimen changes from Yellow to Red  (positive). 
 Histologic examination equals or even surpasses culture, especially 
when positive. However, the patchy nature of the infection requires 
examination of a minimum of two biopsies: One from the gastric antrum 
and one from the fundus. The greater the number of biopsies examined, 
the greater the diagnostic yield, especially in individuals with light 
infections. Mucosal biopsies have the advantage of allowing one to 
examine the mucosa for the presence of gastritis or other lesions. Careful 
examination of four specimens, two from the antrum and two from the 
corpus, has a high probability of establishing the correct diagnosis of the 
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infection. The bacteria are generally readily apparent on H&E-stained 
sections but the infection may be focal and patchy or there may be only 
sparse organisms, especially if intestinal metaplasia is present.70 
H.pylori usually detected in gastric antral mucosa and corpus but 
they are very rare to colonise the cardia. In patient having intestinal 
metplasia and severe atrophy ,the organism usually identified adjacent 
non metaplastic and non atrophy areas. They also transform from spiral 
shape into atypical coccoid forms in unsuitable condition such as usage of 
proton pump inhibitor or antibiotic etc.,this coccoid form indicates the 
degenerated forms of H.pylori and they are avirulent.71A number of 
special stains aid in H.pylori detection including Dieterle silver, Warthin-
Starry, Gram, toluidine blue, Giemsa, Wright-Giemsa, Brown-Hopps, 
acridine orange, or Diff-Quik stains. In addition, there are good 
immunohistochemical reagents that detect the organism. These are 
particularly useful in detecting the coccoid forms of the bacteria.  
One can also identify H.pylori in routinely prepared cytology 
specimens. Gastric mucosal brushings sample larger surface areas than a 
biopsy, thus serving as a useful adjunctive diagnostic test. H.pylori 
bacteria are easily detected microscopically in smears stained with H&E, 
(modified) Giemsa, Papanicolaou and silver-based stains (Warthin-Starry 
and Steiner). The availability of an anti-H.pylori polyclonal antibody 
allows immunohistochemical identification. Other procedures have been 
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described such as, determination of gastric juice ammonia and reverse 
transcriptase- polymerase chain reaction (RT- PCR) amplification as well 
as methods for identifying specific genotypes employing random 
amplified polymorphic DNA analysis (DNA fingerprinting). 
Since culture, cytologic and histologic examination and rapid 
urease-based examinations all require endoscopy, less expensive and 
noninvasive diagnostic tests have been developed; the most popular is the 
urea breath test. They are indicated for the initial diagnosis of the 
infection and to follow patients for infection eradication. In this test 
patient is ask to swallow the urea labelled with radioactive isotope,the 
result of this test shows detection of isotope labelled carbondioxide in the 
exhaled breath which indicates that urea was split into ammonia  by the 
enzyme urease which is produced in abundant by H.pylori organism 
present in the gastric mucosa. This test proves presence of H.pylori  
infection. 
H.pylori bacteria elicit antibody responses, allowing serologic 
testing. Serum enzyme-linked immunosorbent assays (ELISA) tests 
detect H.pylori antibodies and indicate current or past infection. The test 
has a sensitivity of 80% to 100% and a specificity of 75% to 100%.There 
may be variations in the sensitivity based on strain differences. Serologic 
testing is not useful for detecting infection elimination. Stool antigen tests 
can be used to follow patients to determine if the infection has been 
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eradicated if used after 8 weeks following treatment. They are 
particularly useful in children.Other noninvasive methods includes assays 
for exhaled C and C- labeled urea.72 
At last coming to the Immunohistochemistry(IHC),it is an time 
consuming  and very costly procedure approximately takes one to twenty 
four hours but sensitivity and specificity is very high because H.pylori 
can be easily identified in the slides. Immunohistochemistry involves two 
disciplines – immunology and histology.Immunohistochemistry is used to 
determine expression of particular antigen and its micro anatomic 
location in the tissue. IHC uses antibodies to distinguish the antigenic 
differences between the cells. These differences can specifically identify 
the lineage of cell population and define biologically distinct populations 
of cells within the same lineage. In Direct labelling method Antibody is 
attached with a label by chemical means and directly applied to tissue 
sections. It is a rapid and easy procedure and carries the disadvantage of 
multiple antigens which require separate incubation with respective 
antibodies. In Indirect labelling method enzymes are labelled with the 
secondary antibody, which is produced against primary antibody. This 
method is more sensitive and easy to handle. The advantages also include 
increased versality, higher working dilution of primary antibody, 
secondary antibodies against primary antibodies of different species and 
easy to prepare.73 
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ESOPHAGEAL LESIONS: 
ESOPHAGITIS: 
Esophagitis has many causes, the most common being 
gastroesophageal reflux, infections and drugs. Esophageal biopsies are 
taken to determine the etiology of the esophagitis, to assess the 
consequences of the inflammation, to follow the course of the underlying 
disease and to gauge therapeutic responses.  
Esophageal inflammation can be acute, chronic, or mixed. Mild 
esophageal injury results in reversible mucosal changes and transient 
inflammation. Changes associated with acute damage include the 
presence of balloon cells and inflammatory cells (particularly 
mononuclear cells) and eosinophils. Basal cell hyperplasia and papillary 
elongation develop and vascular lakes form. In severe esophagitis, ulcers, 
erosions, or neutrophils may be seen. Chronic damage leads to 
submucosal fibrosis or strictures. Patients with longstanding reflux 
esophagitis may develop Barrett esophagus. 
RELATIONSHIP OF REFLUX ESOPHAGITIS TO 
HELICOBACTER PYLORI INFECTIONS: 
Reflux Esophagitis: 
The term gastroesophageal reflux (GER) refers to the retrograde 
flow of gastric and sometimes duodenal contents into the esophagus. 
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Studies addressing the relationship of H.Pylori infection to GERD 
often reach conflicting conclusions. This results from the fact that the 
interplay of H.pylori infections and GERD is complex and complicated 
by the common use of proton pump inhibitor (PPI) therapy in these 
patients. At the heart of the debate is the link between gastric acid 
secretion, H.pylori infection and GERD. In patients with gastric ulcer and 
corpus gastritis, the impact of H.pylori infection varies substantially 
producing wide variation in patterns of acid secretion. Bacterial 
eradication helps in contolling the H.pylori induced gastritis and its 
complication but in case of GERD it plays a controversial role because 
eradication of organism results in increase hydrochloric acid secretion 
and thereby increase the aggressiveness of refluxed gastric juice to the 
esophageal mucosa. In contrast, duodenal ulcer patients typically have 
antrum-predominant H.pylori gastritis and a well-preserved acid-
secreting mucosa. In these patients, H.pylori infections may make the 
acid-secretory mechanism hyperresponsive to stimulation, increasing acid 
production. In this patient group, H.pylori infections can increase the 
aggressiveness of the gastric juice to the esophageal mucosa.so thereby 
eradication of H.pylori results increase in GERD prevalence.74 
Approximately one third of patients with chronic GERD symptoms 
are endoscopically normal. Low-grade esophagitis is only evident 
histopathologically. Areas of patchy erythema and red streaks are the first 
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endoscopic abnormalities. Later erosions and ulcers develop; these 
predominate distally and taper off proximally. The esophagus appears 
friable, diffusely reddened and hemorrhagic it bleeds easily. As the 
disease progresses, the ulcers become confluent, even circumferential. 
Strictures or Barrett’s esophagus characterize severe chronic disease. 
Prolonged reflux may result in esophageal shortening. Inflammatory 
polyps may be present. The distinction between the squamous and the 
columnar epithelium becomes less clear. Several endoscopic 
classifications have been developed to evaluate the esophageal mucosa.75 
HISTOLOGIC FEATURES 
Biopsies are performed to confirm the diagnosis of GERD to 
document complications, including esophagitis, BE or tumor 
development; and to rule out the presence of coexisting infections.  
Repetitive episodes of tissue injury and healing produce histologic 
features that reflect disease activity at the time of  examination, 
superimposed on changes from previous injurious episodes. Biopsies 
from patients with heartburn commonly show only basal cell hyperplasia 
without inflammation. The basal hyperplasia can progress to frank 
esophagitis. There are four stages of reflux esophagitis: (a) acute 
(necrosis, inflammation and granulation tissue formation); (b) repair 
(basal cell hyperplasia and elongation of the papillae); (c) chronic 
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(fibrosis and formation of Barrett esophagus); and (d) complications 
(dysplasia and adenocarcinoma). 
BARRETT’S ESOPHAGUS(BE): 
Barrett’s esophagus(BE)is an acquired metaplastic change that 
results from longstanding GERD. It results from a combination of 
substances in the refluxate including acid, bile salts, lysophospholipids 
and activated pancreatic enzymes. In this abnormal milieu, multipotential 
immature stem cells differentiate into various epithelial types, including 
columnar epithelium, which is more resistant to acidic digestion and 
which is able to regenerate more rapidly than the native squamous 
epithelium . Once established, Barrett’s esophagus is a highly 
proliferative mucosa. 
The development of Barrett’s esophagus is a multistep process with 
at least three distinct phases. During the initiation phase, genetically 
predisposed patient suffering from GERD develop reflux esophagitis. 
This leads to the formation of a metaplastic epithelium with features of 
intestinal columnar epithelium. The metaplastic columnar cells of 
Barrett’s esophagus could derive from three sources: (a) metaplasia of 
squamous epithelium, similar to that seen with vaginal mucinosis; (b) 
from the mixed squamous/columnar cell population at the transitional 
zone, as seen in cervical metaplasia; or (c) from the columnar cells of the 
esophageal glands, such as may be associated with ulcer repair. 
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Circulating bone marrow derived stem cells (BDSCs) have been proposed 
to be the source of metaplastic cells in the stomach in response to 
H.pylori gastritis. Recruitment of BDSCs in response to reflux-induced 
inflammation might serve as another potential source of Barrett’s 
esophagus. 
During the formation stage, the metaplastic epithelium exposed 
continuously refluxed acid content will results increase in metaplastic 
changes . A long and multifaceted progression phase follows, during this 
phase metaplastic epithelium progress into dysplasia and the end results 
in adenocarcnioma. 76 
GROSS AND ENDOSCOPIC FEATURES: 
Barrett’s esophagus appears beefy red and velvety, contrasting with 
the lighter pink-tan colored, smooth squamous mucosa. The Squamo 
Coloumnar Junction(SGJ) often lies within 30 cm of the incisor teeth and 
often coexists with a hiatal hernia, strictures, diffuse esophagitis, or 
esophageal ulcers. Grossly, there are several distinct patterns of Barrett’s 
esophagus: Circumferential, islands and finger like projections or 
tongues. The island type accompanies less severe epithelial injury than 
the circumferential type and probably represents an earlier stage, which 
then progresses to the circumferential lesion. Sometimes it is difficult to 
distinguish the distal border of the metaplastic epithelium from the 
adjacent gastric mucosa with which it may appear to merge. Locating the 
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gastric folds helps delineate the beginning of the stomach. Patients with 
Short Segment Barrett Esophagus (SSBE) have short tongues or patches 
of red mucosa lying <2 cm above the gatroesophageal junction(GEJ). 
Since it may be difficult to endoscopically distinguish areas of 
intestinal metaplasia from other columnar epithelium, various additional 
endoscopic approaches may be used to evaluate the mucosa. These 
include magnification endoscopy, endoscopic optical coherence 
tomography, chromoendoscopy, endoscopic confocal imaging, light-
scattering spectroscopy and in vivo fluorescence endomicroscopy. These 
advanced imaging methods may enable the endoscopist to detect 
intestinal metaplasia in a background of gastric epithelium; to detect foci 
of dysplasia and early neoplasia in a background of intestinal metaplasia; 
and to distinguish early invasive carcinoma from mucosal dysplasia 77 
Typically the endoscopist biopsies the following areas: The 
stomach just distal to the upper end of the gastric folds, particularly along 
the lesser curvature; 1 to 2 cm above the GEJ; tongues of mucosa or 
irregular areas above the SCJ; and the SCJ and squamous epithelium of 
the native esophagus. Biopsies at the upper end of the gastric folds may 
allow one to determine whether there is gastritis, particularly H.pylori 
induced gastritis and possibly intestinal metaplasia. This biopsy may be 
within a hiatal hernia. These biopsies can detect localized carditis, 
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localized intestinal metaplasia, reactive changes, acute inflammation and 
possibly eosinophils in the squamous mucosa. 
HISTOLOGY OF BARRETT’S ESOPHAGUS 
There are two major problems in the pathologic evaluation of 
patients with Barrett’s esophagus: Overdiagnosis of Barrett’s esophagus 
and overdiagnosis of dysplasia in the setting of Barrett’s esophagus.  The 
histology of the columnar-lined esophagus displays heterogeneous 
histologic features with respect to the types of glandular mucosa that are 
present and the surface architecture. The definition of  Barrett’s 
esophagus requires histologic confirmation of intestinal metaplasia in 
biopsies taken from the columnar regions of the esophagus. The 
metaplastic Barrett’s esophagus epithelium resembles either small 
intestinal absorptive cells (complete intestinal metaplasia) or incomplete 
intestinal metaplasia (resembling colonic epithelium). In the latter, the 
cells lack a distinct brush border and the associated enzymes that 
normally characterize small intestinal absorptive cells. There is debate 
over whether incomplete metaplasia poses a higher risk than the complete 
type, but since both types confer a neoplastic risk, subtyping is not 
indicated. If any goblet cells are seen, one can make the diagnosis of 
Barrett’s esophagus when the biopsy derives from the esophagus . 
Examination of multiple biopsies and multiple levels helps identify 
this patchy process. The epithelium covering the mucosal surface and pits 
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commonly contains a mixture of gastric foveolar cells and intestinal cells. 
The latter include goblet cells, intestinal columnar cells, endocrine cells 
(containing serotonin, somatostatin, calcitonin, pancreatic polypeptide 
and secretin)  and sometimes Paneth cells. The majority of the intestinal 
columnar cells are so-called intermediate, principal, or pseudoabsorptive 
cells that have characteristics of both absorptive and secretory cells. A 
villiform architecture may be present on the surface. H. pylori may be 
found in the esophagus of some patients with Barrett’s esophagus but 
only when it is also present in the stomach. It may contribute to the 
severity of the inflammation seen in Barrett’s esophagus. 
Goblet cells are usually readily identifiable in H&E-stained 
sections by their round supranuclear mucin accumulation. While goblet 
cells contain acidic mucin that stains intensely blue with Alcian blue 
staining at pH 2.5, routine Alcian blue staining is usually not necessary. 
Alcian blue positive cells are also found in normal esophageal 
submucosal glands and their ducts. These submucosal glands are readily 
distinguished from Barrett’s esophagus because of their rounded, grouped 
lobular configuration and their resemblance to minor salivary glands as 
well as by their diffuse positivity for Alcian blue at pH 2.5. The entire 
esophageal glandular lobules stain intensely contrasting with the 
individually scattered intensely positive goblet cells typical of Barrett’s 
esophagus. 
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Careful histologic attention should be paid to potential Barrett’s 
esophagusmimics, particularly pseudogoblet cells. These columnar cells 
are hyperdistended gastric foveolar cells. They contain a mucinous 
droplet that is larger than the typical foveolar cell but smaller than the 
usual goblet cell. They occur in the surface epithelium at the GEJ and 
distal esophagus. They may occur in the presence or absence of true 
goblet cells. The cells stain positively with Alcian blue at a pH 2.5; for 
this reason they are sometimes referred to as the columnar blue. 
However, the pseudogoblet cells stain less intensely than true goblet cells. 
If only Alcian blue positive columnar cells are present in the absence of 
true goblet cells, the diagnosis of Barrett’s esophagus should not be made. 
Because of the lack of specificity of Alcian blue staining for true goblet 
cells, there has been interest in finding a more specific marker of 
intestinal goblet cells. Markers of interest have included stains for 
sulphomucins and sialomucins. Another promising marker is MUC2, 
which may be specific for intestinal metaplasia in Barrett’s esophagus .78 
Of note, the muscularis mucosae is hyperplastic in the distal 
esophagus and in some areas collagen-rich fibrous tissue replaces the 
muscularis mucosae. An understanding of these features is important in 
two situations: The first is the correct interpretation of alterations that 
may affect the submucosal glands and the second is  the correct staging of 
invasive malignancies . The fibroblastic or muscular abnormalities may 
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deform the ducts of the submucosal glands, causing the glands to dilate. 
The combination of irregular ductal compression in the presence of 
atypical epithelial cells lying in the fibrous tissue can cause difficulty in 
differentiating normal or dysplastic esophageal glands trapped in the 
collagen-rich fibrotic tissue from invasive cancer .79 
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MATERIALS AND METHODS 
This study was proposed and conducted in the Tirunelveli Medical 
College Hospital.  A pilot study was done and approval of the ethical 
committee of the Tirunelveli Medical College & Hospital was obtained.  
Patients presented to the outpatient department of the Department 
of Medical Gastroenterology at Tirunelveli Medical College Hospital and 
a private Medical Gastroenterology Clinic, during the period - January 
2010 to September 2012. A total of 145 cases presenting with features of 
acid peptic disease and GERD were examined, in that 100 patients were 
selected for our study based on a set of inclusion and exclusion criteria. 
Exclusion criteria includes patients with acute gastritis,complications like 
bleeding and patient with gastric malignancy/esophageal malignancy.  
Endoscopy was carried out using Olympus GIFSQ 30 video 
endoscopy system in the Department of Medical Gastroentrology at the 
Tirunelveli Medical College and  Hospital.   Endoscopy finding was 
recorded using a standard proforma . Biopsy samples was taken from 
sites of antrum of stomach .Concurrent examination of the esophagus was 
done in all these cases and biopsies were taken from them.We received 
biopsy of the esopahgus from 76 cases. 
 The specimens were immediately fixed in 10% formalin and 
processed routinely. Four microns sections were taken from both the 
tissues and stained with hematoxylin and eosin. Sections were also 
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stained with special stain using carbol fuchsin and light green 
counterstain for detection of Helicobacter pylori and with the 
conventional Warthin –Starry silver stain for detection of Helicobacter 
pylori. 
Each section was analysed for the presence of epithelial changes 
which includes surface irregularity, epithelial pits ,drop out necrosis and 
microerosion. The histological changes such as inflammation,mucosal 
atrophy ,neutrophilic activity , intestinal metaplasia and H.pylori status 
was graded according to the Sydney system. The results and observations 
were tabulated and analysed for their significance. An attempt was made 
to study the efficiency of a stain for demonstrating helicobacter pylori in 
gastric biopsies using dilute carbol fuchsin light green stain and 
comparison were made with that of warthin starry stain. 
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HAEMATOXYLIN AND EOSIN (H&E): 
Procedure 
1. Dewax the section and hydrate through graded alcohols to water. 
2. Remove fixation pigments if needed. 
3. Stain with Harris Haematoxylin for 2-3 minutes. 
4. Wash in running tap water . 
5. Differentiate in 1% Acid Alcohol( 1 per cent HCL in 70 percent 
alcohol) for 5-10 sec. 
6. Wash and blue with running tap water until the section turns blue, 
followed by tap water wash. 
7. Counter stain with aqueous eosin for 2 minutes. 
8. Dehydrate with absolute alcohol (2-3changes). 
9. Clear with 2-3 changes of xylene. 
10. Mount using Dibutyl phthalate Polystyrene Xylene (DPX). 
Results : 
Nuclei   : Blue 
Cytoplasm  : Varying shades of pink 
Muscle fibers : Deep pink/red 
Red blood cells : Orange/red 
Fibrin   : Deep pink 
Organism   : Pink 
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CARBOL FUCHSIN AND  LIGHT GREEN STAIN : 
Specimens : 
For fixation of the gastric biopsies Formalin is used   
Controls : 
H.pylori positive tissue were used as controls all the times . 
Staining solutions: 
Working solution:  For carbol fuchsin 
 Carbol fuchsin-20ml 
 Distilled water-80ml 
Light green counterstain in Gallegos (Brown and Hopps 
1972)differentiating solution: 
 Distilled water-97ml 
 40%formaldehyde-2ml 
 Glacial acetic acid-1ml 
 Add 20 drops of 2% light green 
Twenty drops of 2% light green per 100ml of Gallegos solution is 
recommended for a pale counterstain that should not mask any 
organisms, but can be adjusted to suit the users preferences. 
Light green 2% in 1% acetic acid  
 Distilled water -99ml 
 Glacial acetic acid-1ml 
 Light green-2g 
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Acetic acid 0.1% in 90% ethanol 
 Absolute ethanol-90ml 
 1%aqueous acetic acid-10ml 
Staining procedure: 
1. Dewax in Xylene, hydrate through graded alcohol and bring the 
section to   water. 
2. Rinse in buffered distilled water (pH 6.8). 
3. Stain with dilute carbol fuchsin 5 -10min. 
4. Wash the section in running tap water. 
5. Rinse with absolute ethanol for 10 seconds until the red colour 
disappear.  
6. Again Wash the section in running tap water. 
7. Dip the section in light green for 1 minute which acts as counterstain. 
8. Rinse briefly with 0.1% acetic acid in 90% ethanol. This rinse after 
differentiation assists in removing backround staining and initiates 
dehyhydration. 
9. Dehydrate rapidly in absolute ethanol. 
10. Clear in two or three changes of xylene. 
11. Mount in DPX. 
Results : 
 H.pylori     -  Takes Bright red  
 Gastring lining   -  Pale green 
 Nuclei and other cell structures -  Shades of pink to red    
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WARTHIN –STARRY SILVER STAIN   
PROCEDURE 
Sections 
Formalin-fixed , paraffin sections. 
Solutions  
 Acetate buffer,PH 3.6 
 Sodium acetate : 4.1 g 
 Acetic acid        : 6.25ml 
 Distilled water   : 500ml 
1%silver nitrate in pH 3.6 acetate buffer. 
Developer 3 g of hydroquinone in 10ml pH 3.6 buffer and mix 1ml 
of this solution and 15ml of warmed 5% scotch glue or gelatine; keep at 
40 degree celcius. Take 3 ml of 2% silver nitrate in pH 3.6 buffer solution 
and keep at 55 degree celcius mix these two solutions immediately before 
use.  
Method 
1. Deparaffinize and rehydrate through graded alcohols to distilled water. 
2. Celloidinize in 0.5% celloidin,drain and harden in distilled water-
1min. 
3. Impregnate in pre-heated 55-60 degree celcius silver solution(b),90-
105 minutes. 
4. Prepare and preheat developer in a water bath. 
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5. Treat with developer(solution c) for 31/2 minutes at 55 degree celcius. 
Section should be golden-brown at this point . 
6. Remove from developer and rinse in tap water for several minutes at 
55-60 degree celcius, then buffer at room temperature. 
7. Tone in 0.2% gold chloride . 
8. Dehydrate, clear and mount . 
Results  
 Spirochetes   :  Black   
 Background   : Golden yellow  
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
OBSERVATION AND RESULTS 
TABLE :I 
Age and gender distribution of 100 patients presented with gastritis 
Age  No. Of patient  No. Of Male patient No.Of Female patient 
11-20 5 3 2 
21-30 20 16 4 
31-40 26 17 8 
41-50 18 9 10 
51-60 9 7 2 
61-70 12 8 4 
>70 10 10 0 
Total 100 69 31 
 
In hundred cases of gastric biopsies studied, sixty nine cases (69%) were 
males and thirty one cases (31%) were females with a male to female 
ratio of 2.22:1. Of the 100 patients studied, the age ranging from 11 to 84 
years (Table 1) with a mean age of 35.54 years. Peak incidence of 
occurrence of gastric lesions were third and fourth decade with twenty 
cases(20%) and twenty six cases(26%) respectively. 
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TABLE II: 
Clinical symptoms for patient with gastritis  
Clinical symptoms 
Number of patient with   
symptoms 
Nausea  78 
Vomiting  67 
Abdominal pain 89 
Heart burn 92 
 
Patient with chronic gastritis mostly presented with following 
symptoms such as nausea, vomiting, abdominal pain and heart 
burn.Among the clinical features in this present study most common was 
heart burn followed by pain abdomen and nausea and most of the patient 
presented with more than one symptoms in our study [Table II]. 
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TABLE:III 
Helicobacter pylori status in various age groups 
Age  No. Of patient  H.pylori positive H.pylori negative  
11-20 5 1 4 
21-30 20 10 10 
31-40 26 18 8 
41-50 18 14 4 
51-60 9 7 2 
61-70 12 8 4 
>70 10 6 4 
Total 100 64 36 
 
The age distribution of H.pylori shows a peak incidence at fourth to fifth 
decade  patient . Predominantly fourth decade patient shows peak 
incidence of H.pylori infection.In fourth decade patient among 26 patient 
18 patient were found to be positive for H.pylori infection in our 
positivity. After that the incidence of H.pylori infection is decreased with 
increase in age (Table III).  
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TABLE  IV: 
Helicobacter pylori status in gender  
Sex No . of patient  H.pylori positive  H.pylori negative  
Male 69 44 25 
Female 31 20 11 
Total 100 64 36 
 
In our study, among the sixty four cases of Helicobacter pylori 
associated gastritis , fourty four (68.75%) were males and twenty (31.5%) 
were females with a ratio of 2.2:1. This shows male predominance for 
H.pylori infection (Table IV).  
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TABLE V: 
Comparison of H.pylori status with that of inflammation, activity, 
atrophy and intestinal metaplasia 
Mucosal changes  Total no. of cases  H.pylori positivity Percentage  
Inflammation  
1)Mild  
2)Moderate 
3)Severe 
 
27 
47 
15 
 
9 
41 
14 
 
33.3% 
87.23% 
93.33% 
Activity  65 55 84.6% 
Atrophy  33 23 69.6% 
Intestinal 
metaplasia  
22 16 72.7% 
 
In our present study number of antral biopsies with significant 
inflammation ,activity,intestinal metaplasia and atrophy were analysed 
and graded according to the Modified Sydney system.  We had 27 cases 
with mild inflammation ,47 with moderate inflammation and 15 cases 
with severe inflammation .Correlating the H pylori positivity status with 
that of the type of inflammation,we had 33.3% positivity in mild 
inflammation,87.23% positivity in moderate inflammation and 93.33 % 
positivity in cases with severe inflammation. This observation is 
statistically significant. The positivity rate increases with that of the 
density of the bacteria.
 Accounting the activity status in the 65 cases of our study 55 cases 
[84.60%] showed positivity for 
metaplasia in our present  72.7% [16 cases] were shown positivity for 
H.pylori organism.(Fig 1
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 CHART 5: 
Association of H.pylori infection with activity,atrophy and intestinal 
metaplasia 
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TABLE VI: 
Histomorphological Changes in H pylori Positive Chronic Gastritis 
Nature of Lesion No of cases 
Mucosal Hyperemia  50 
Mucosal edema 52 
Surface epithelial degeneration 49 
Focal epithelial regeneration 38 
Surface erosion 54 
Foveolar hyperplasia 38 
Lymphoid aggregates 56 
Lymphoid follicles 50 
Eosinophilic infiltration 12 
Intestinal Metaplasia 16 
Atrophy 33 
Total cases 64 
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TABLE VII: 
Comparison of H.pylori positivity with light green carbol fuchsin 
stain and Warthin Starry stain 
H.pylori status Light green carbol fuchsin Warthin starry stain 
H.pylori positivity  61 57 
H.pylori negative 39 43 
 
In our present study apart from conventional H&E stain to detect H.pylori 
,we made a attempt to detect the H.pylori organism using Light green 
stain and compare the staining qualities with that of Warthin – Starry 
Silver stain .We found that in 61 cases we were able to detect the 
organism using Light green carbol fuchsin and in  57 cases using Warthin 
–Starry stain. Both the stains were  positive for 56 cases.(Fig 18-24)  
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TABLE VIII: 
Male and female distribution of positive & negative cases of 
Helicobacter pylori in warthin  and a stain using carbol fuchsin and 
light green as counter stain: 
Method 
Warthin starry stain 
Carbol fuchsin and light 
green stain 
POSITIVE NEGATIVE POSITIVE NEGATIVE 
Male  41 28 43 26 
Female  
16 15 18 13 
Total number of 
cases  
57 43 61 39 
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TABLE IX: 
Comparison of various factors between light green carbol fushin and 
warthin starry stain : 
Special stain Relative cost Average time 
Reproducibility 
of technique 
Warthin starry  Expensive 2hrs Relatively Good 
Carbol fuchsin 
light green  
Cheaper 10-15min Good 
 
In our study we also made comparison about the relative 
cost,average time and reproducibility of technique between Warthin 
starry and carbol fuchsin light green . In that we found that Light green 
carbol fuchsin is better than that of Warthin starry stain as it is cheaper, 
less time consuming and detection of the bacteria is easier (pink spiral 
forms against green background) and for easy reproducibility of 
technique.The problem we encountered with Light Green was in cases 
with less number of bacteria, in which Warthin- Starry stain was much 
better. 
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TABLE X: 
Distribution of various esophageal lesion: 
Distribution of esophageal lesion Number of cases 
Chronic reflex esophagitis 28 
Chronic non specific esophagitis 18 
Vascular ectopia 10 
Barrets esophagus 14 
Normal histology 06 
Total cases 76 
 
Endoscopic appearance of the esophagus was also studied in the 
process of evaluating the cause for the acid peptic disease and 
GERD.Biopsies were taken from the lesions as and when necessary.  
We had esophageal biopsies taken from 76 cases out of the total 
100 cases. In that 6 of the cases the esophagus did not show any 
remarkable pathological changes. 
The most common esophageal lesion seen in our series of patients 
was that of Chronic Reflux Esophagitis 28 cases (36.8%), followed by 
chronic non specific esophagitis with 18 cases .The next significant 
esophageal pathology noted was that of Barrett’s esophagus in 14 of our 
cases (18.42%) followed by vascular ectasia of esophagus 10 cases.                  
(Fig 25,26) 
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DISCUSSION 
The present study was conducted on 145 cases of patients 
presenting with symptoms of acid peptic disease to the outpatient clinic 
of Medical gastroenterology and a private Gastroenterology clinic at 
Tirunelveli.The endoscopy study was done on 100 cases only and 
necessary biopsies were taken from them for the study. 
The overall positivity of  H pylori in our study was 64% (64 cases 
out of 100 cases) (Table IV). This is close to the observations of Vijaya 
VA et al (1999)80 who found a positivity of 61.4% in her series, Abbas et 
al (2001)81 found a positivity of 62% in  his study on Pakistani 
population,Manes et al (1999)82 in a case control study carried out in Italy 
found a positivity of 62% .However Misra et al (2001)83 had a higher 
positivity of 71% in his series of cases studied for the prevalence of 
H.pylori in gastric antral biopsies. 
The study population comprised of patients with age ranging from 
11 to 84 (Mean age was 35.54%).The maximum number of cases were 
belonging to 4 th decade (26% ),followed by 3 rd decade with 20 cases 
(Table I).This is akin with the observations of  Abbas et al (2001)81 who 
had a mean age of 45 years & Csendes et al (1997)84with a mean age of 
43 years.  
Correlating the H pylori positivity with the age of the individuals, 
there is a gradual increase in the incidence of H pylori status with the age 
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of the individuals.The positivity is 50% in the age group of  21-30 
years,and it gradually ascends to 69% in the age group of 31-40 years 
with much higher percentage of 77.7% seen in age group of 41- 60 years. 
There is a slight fall in the positivity rate in individuals more than 60 
years. The percentage of positivity is 66.6% and 60% respectively (Table 
III) .This is similar to the observations of  Vijaya VA (1999)80 who found 
a peak positivity rate of 67.2% in age group of 31-40 years followed by 
63.8% in 50 to 59 years of age.She had also reported a fall in the 
positivity rate after 60 years .Our observations of fall in positivity 
correlates well with this study.In her study she had observed a very high 
percentage of 69.3% in patients belonging to age group of 20 to 29 years 
which we did not find in our series. We had a positivity of only 50 % in 
those cases.  
Regarding the gender distribution of cases , men out numbered 
women in our series close to the observations of literature. We had 69 
male cases and 31 female cases. The M: F ratio being 2.2 :1(Table I).This 
is similar to the observations made by Niv et al (1996)85 who found a 
ratio of 1.6:1 in their series.Correlating the positivity status to the gender 
of the study group, H pylori positivity was found in 63.7  % of men and 
64.5  % women with a mean positivy of 64 %.This observation also 
correlates well with that of Vijaya VA et al (1999) loc.cit80 who found a 
positivity of  63.1% in the men and 56.5% in women. 
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The number of antral biopsies with significant inflammation was 
analysed and grade according to the Modified Sydney system.We had 27 
cases in mild inflammation,47 cases with moderate inflammation and 15 
cases with severe inflammation.Correlating the H pylori positivity status 
with that of the type of inflammation,we had 33.3% positivity in mild 
inflammation,87.23% positivity in moderate inflammation and 93.33 % 
positivity in cases with severe inflammation(Table V).This correlates 
well with the study of Vijaya VA et al loc.cit (1999)80 who found a 
positivity of 57% in cases with mild inflammation,88.4% in cases with 
moderate inflammation and 100% in cases with severe inflammation.It 
thus justifies the significant association of presence of inflammation and 
the H pylori positivity.We had a lesser percentage of positive cases with 
severe inflammation when compared with the study cited above.Higher 
positivity was observed in cases with moderate inflammation in our 
study.Another significant observation made in the present study was 
greater density of organisms was found with higher grade of 
inflammation.In mild inflammation the presence of inflammatory cells 
were restricted to the superficial mucosa at the level of the pits, neck of 
pyloric glands and the lamina propria whereas in severe inflammation the 
cells infiltrated deep into the muscularis mucosae. 
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Regarding activity status we had 65 cases with activity according 
to the Sydney scoring system.Analysis of the H pylori status in these 
cases showed a positivity of 84.6% (55 cases)(Table V).This is similar to 
the observations of Charanjeet et al (2001)86 with 90.4% and Vijaya VA 
et al loc.cit (1999)80 with 91.4%.The positivity of the H. pylori with the 
activity status was statistically significant. 
We had 22 cases with intestinal metaplasia in our biopsy series.The 
positivity status for H.pylori in this group was 72.7% (16 cases)(Table 
V).The positivity status is similar to the observations made by Vijaya VA 
et al loc.cit (1999)80 with 78.2% positivity.This goes in contrast to the 
observations made by Charanjeet et al (2001)86 in his series on 50 cases, 
found a low H.pylori positivity of 25 %. We found that intestinal 
metaplasia was significantly more common in H.pylori positive biopsies. 
The organisms were not seen in the metaplastic epithelium but were seen 
in the adjacent gastric mucosa. 
We had a significantly large number of cases (33 cases out of 100) 
presenting with atrophy of the gastric mucosa with with widely spaces 
pits with villiform mucosa and glands lined by low cuboidal cells with 
depletion of mucin(Table V).Vatsala et al (2001)83 had 31 cases reported 
in her series. Vijaya VA et al loc cit (1999)80 had a very low number of 
cases with atrophy in her study population. Analysis of H pylori status in 
cases of atrophic gastritis, we had a positivity in 23 of our cases (69.6%) . 
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Many authors have observed that development and extension of atrophic 
gastritis was more common in H pylori positivity than in negative cases 
.kohli Y et al (1993)87,Sakaki et al (2002)88and Gilvarry JM et al (1994)89. 
The determinants of atrophy represent a process leading to the loss of 
glands in the gastric mucosa.This results from impaired epithelial 
regeneration.The bacteria through its inflammatory mediators induces 
degeneration of the glandular epithelial cells and also interferes with the 
regenerating capacity of the glands. 
A detailed analysis of the histomorpholgical changes noted in the 
antral biopsy specimens in cases of H pylori positivity is given in the 
table VI. 
Mucosal Hyperemia and Edema : 
Mucosal hyperemia  and edema are often endoscopic or pathologic 
indicators of chemical injury. However, congestion and edema  may also 
be prominent features in H. pylori  associated gastritis due to the 
underlying inflammatory processes .In our study we had observed 
mucosal edema and congestion in most of our cases  
Surface Epithelial Degeneration : 
Surface epithelium degeneration is considered a nonspecific 
response to injury seen, to a variable degree, in all forms of gastritis. 
However, it is most conspicuous in two particular disorders: chemical 
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gastritis (resulting from bile reflux, ethanol, or NSAID use) and H. Pylori 
gastritis. 
We studied this particular change in all the biopsies which was 
stained positive for H pylori .The most common observation we found 
was the transformation of normal columnar epithelial cell into cuboidal-
shaped epithelium along with mucin depletion.The depletion of mucin 
was  obvious in the lining  foveolar cells.These changes are found in  
most of the cases of H. pylori gastritis, even in areas where the organism 
found to be scanty.  
Focal epithelial Regeneration : 
We also observed focal epithelial regeneration of the cells with 
piling up of epithelial cells at the surface of the mucosa in few of our 
cases, This matches with the observations made by the authors who 
termed it as epithelial regeneration ,which is made up of multiple cells at 
the surface of the mucosa ,a well known feature of H. pylori gastritis. 
Surface erosion : 
We observed superfical epithelial erosions in most of our cases.The 
erosions were associated with neutrophilic infiltration with areas of 
edema. H.pylori associated surface erosion endoscopically appear as 
elevated lesion and microscopically they present with central fibrinod 
necrosis along with neutrophils and cellular debris and their margin 
shows both hyperplastic and regenerative changes. 
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Foveolar Hyperplasia : 
In our study we found antral mucosa lined by low cuboidal cells 
with increase nuclear cytoplasmic ratio with hyperchromatic nuclei and 
mitotic activity  admixed with depletion of mucin .This accounts for the 
terminology of pit hyperplasia. 
Lymphoid Aggregates and Follicles : 
In normal person usually gastric mucosa will show small 
aggregates of lymphoid cell near muscularis mucosae or at the base of 
lamina propria but in case of H.pylori associated gastritis lymphoid 
follicles will be seen with germinal centers. 
 In our series we have observed presence of lymphoid aggregates in 
most of the cases with H. pylori positivity   56 cases (87.5%)and in many 
cases we observed formation of prominent lymphoid follicles with 
prominent germinal centre 50 cases (78.1%). Other studies were 
concordance with our study they found that lymphoid follicles or 
aggregates have been detected in virtually all subjects with H. pylori 
gastritis.So it is well known factor from our study and other study 
presence of lymphoid follicle is strongly suggest the presence of H.pylori 
infection.  
Intestinal Metaplasia : 
We had 22 cases presenting with intestinal metaplasia of which 16 
were positive for H.pylori. The bacteria was identified at the adjacent 
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gastric mucosa and it is negative in the metaplastic epithelium. Several 
studies have shown that intestinal metaplasia occurs more frequently in 
patients with H. pylori gastritis. 
Atrophy : 
In our study we had 33 cases presenting with features of gastric 
atrophy of which 23 (69.6%) were positive of H.pylori. 
Eosinophil Infiltration : 
In normal patient few eosinophils usually present in the lamina 
propria.But in H.pylori associated gastritis there will be mild eosinophil 
infiltration will be seen along with other inflammatory cells . In our study 
We had significant infiltration of eosinophils in very few of our cases (12 
cases). 
Histological Identification of Helicobacter pylori – Comparison of 
staining Methods : 
For the past decades many authors were undergone various 
investigatory  methods for detecting the spiral shape organism in the 
gastric mucosa and its association with gastrointestinal diseases . Atlast 
they succeeded with their effort and found that H.pylori organism plays 
an important role in the etiology of many gastrointestinal diseases. 
H.pylori has been established as a major cause for chronic gastritis . So 
its identification and eradictation is significantly important to save the life 
of the patient form H.pylori asscoicated diseases .so it is in the hands of 
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pathologist to give accurate diagnosis to help the clinicians and thereby 
saves the patient . Various techniques were adopted both invasive and 
noninvasive to detect the organism used including serology,culture, rapid 
urease test, C13 urea breath test and histology. Among this histological 
detection of H.pylori is gold standard test compare to the other test . 
Many investigators followed different staining method to detect the 
organism such as  modified Giemsa, Warthin –Starry, Gimenez, Genta 
and latest immunohistochemical H pylori antibody stains.In the present 
study we used two stains for identifying the bacteria in the endoscopic 
biopsies.We used the conventional Warthin Starry silver stain and Light 
Green carbol Fuchsin stain for the detection of the bacteria. 
Warthin –Starry as able to pick up the bacteria in 57 cases and 
Light green Carbol Fuchsin stain stained positive for the bacteria in 
61cases.Both the stains were positive in 56 cases and the staining pattern 
was observed by two individual observers without prior 
information(Table VII&VIII). 
We recommend the use of Light Green Carbol Fuchsin stain as an 
alternate for the conventional Warthin Starry silver stain or it can be used 
as an additional staining method for the detection , as it is cheaper, less 
time consuming and detection of the bacteria is easier (pink spiral forms 
against green background)(Table IX). 
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Analysis of the Esophageal Lesions : 
As a part of our study,the endoscopic appearance of the esophagus 
was also studied in the process of evaluating the cause for the acid peptic 
disease.Biopsies were taken from the lesions as and when necessary.  
We had esophageal biopsies taken from 76 cases out of the total 
100 cases. The various histomorphological changes are summarized in 
the table X. 
In 6 of the cases the esophagus did not show any remarkable 
pathological changes. 
The most common esophageal lesion seen in our series of patients 
was that of Chronic Reflux Esophagitis (28 cases) (36.8%), followed by 
chronic non specific esophagitis and others.The case of chronic reflux 
esophagitis was associated with expansion of the basal zone with 
elongation of the  vascular papillae.This correlates well with the 
observation by Collins BJ et al (1996)90 who was of the opinion that this 
is a very significant histological change in patients with chronic reflux 
esophagitis and can be taken as a marker for the reflux disease.Balloon 
degeneration of the epithelial cells is found to be yet another indicator of 
epithelial cell injury and we had 10 cases withthis feature.Jessurun JY et 
al (1988)91 proposed that the presence of these balloon cells indicates 
epithelial injury.Presence of intraepithelial eosinophils is an additional 
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indicatorfor reflux disease .Tummala V et al (1987).92However only 6 of 
our cases shows presence of intraepithelial eosinophils. 
The next significant esophageal pathology noted was that of 
Barrett’s esophagus in 14 of our cases (18.42%).The most common type 
of metaplastic epithelium was that of columnar cells resembling gastric 
mucosal cells. Inflammation was not very significant in the cases of 
Barrett’s esophagus, we had noticed non specific inflammation in 4 cases 
and ulceration in 2 cases.This is in coherence with the observation made 
by Petras RE et al (1991)93who observed that ulceration and inflammation 
are non specific changes associated with Barrett’s esophagus.The other 
histological changes in the esophagus included that of Chronic non 
specific esophagitis and vascular ectasia of esophagus. 
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SUMMARY AND CONCLUSION 
Infection with Helicobacter pylori has been established as the 
major cause of chronic gastritis and is important in the pathogenesis of 
other gastroduodenal diseases such as peptic ulcerations, gastric 
adenocarcinoma and gastric lymphoma. 
In view of this significance,an accurate diagnosis of the infection 
becomes essential to institute eradication treatment in appropriate 
cases.Endoscopic examination of the gastric and esophageal  mucosa  
becomes mandatory in patients with symptoms of acid peptic 
disease.Histological diagnosis of gastric lesions along with detection of H 
pylori becomes a part of the protocol of work up in patients with 
symptoms of acid peptic disease. 
We undertook this study on 145 patients presenting with symptoms 
of acid peptic disease and found significant endoscopic lesions in 100 
patients. They were recruited for the detailed histomorphological study of 
the gastric mucosa along with the use of two special stains for the 
detection of H pylori – Warthin Starry and Light Green Carbol Fuchsin 
stain.The gastric lesions were classified and grade according to the 
Modified Sydney system of classification.The presence of H pylori was 
evaluated with two stains by two independent observers. 
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We had a 64% positivity for H pylori which reveals the common 
prevalence of the organism in the geographic area.Predominant cases (47) 
presented with moderate inflammation and activity.The significant 
histomorpholgical changes were surface epithelial degeneration, focal 
epithelial regeneration, mucosal hyperemia and edema, mucus 
depletion,lymphoid aggregates and lymphoid follicles.We had 33 cases 
presenting with features of atrophy and 22 cases with features of 
intestinal metaplasia.H.pylori staining was positive in cases with 
intestinal metaplasia and atrophy.Warthin starry stain was able to pick up 
the bacteria in 57 cases and Light Green stain picked up the organism in 
61 cases. We recommend the use of both the stains in combination in the 
detection of H pylori. The Light green stain was more economical and 
cheaper than the conventional silver staining techniques.The patient 
diagnosed to be positive for H pylori have been instituted antimicrobial 
therapy and are being followed up frequently. 
Histomorphological analysis of esophagus was done in 76 cases 
and we found the most common histological change was that of chronic 
reflux esophagitis followed by chronic non specific esophagitis, Barrett’s 
esophagus and Vascular ectasia.In few of the cases the esophagus was 
normal.The cases of Barrett’s esophagus are kept under close follow up.  
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Thus we conclude a thorough clinical examination and history, 
followed by endoscopic evaluation and methods to detect presence of H 
pylori organism becomes mandatory in the evaluation of case with 
symptoms of acid peptic disease.Use of combination of special stains 
increases the sensitivity of detection of the organism. 
 
 
  
FIG:1 Photomicroscopic picture of gastric antral mucosa shows normal glands(H&E,X100) 
 
FIG:2 Photomicroscopic picture of gastric antral mucosa shows mild inflammation with mild 
activity and eosinophils(H&E,X100) 
 
 FIG:3 Photomicroscopic picture of gastric antral mucosa shows mild inflammation(H&E,X100) 
 
 
FIG:4  Photomicroscopic picture of gastric antral mucosa shows foveolar pitting with moderate 
inflammation(H&E,X100) 





 
CI ACTIVITY IM ATROPHY H.pylori 
1 1474/11 41 F 3 2 1 0 POS POS POS
2 1475/11 54 F 0 0 1 1 NEG NEG NEG
3 1476/11 40 M 3 1 0 1 POS POS POS
4 1477/11 28 M 2 0 2 0 POS POS POS
5 1478/11 34 M 3 2 0 1 POS POS POS
6 1479/11 26 M 3 0 0 0 POS POS POS
7 1492/11 36 F 1 0 0 0 NEG NEG NEG
8 1493/11 61 F 2 2 0 1 POS POS POS
9 1494/11 68 M 1 0 0 0 NEG NEG NEG
10 1495/11 72 M 0 0 0 1 NEG NEG NEG
11 1496/11 34 M 3 2 0 0 POS POS POS
12 1550/11 44 M 2 2 0 0 POS POS POS
13 1551/11 69 F 2 1 0 0 POS NEG POS
14 1553/11 40 M 2 0 1 2 NEG NEG NEG
15 1554/11 34 M 3 2 1 1 POS POS POS
16 1555/11 39 M 2 2 0 0 POS POS POS
17 1556/11 63 M 2 2 1 2 POS POS POS
18 1557/11 53 M 2 1 0 3 POS POS POS
19 1558/11 39 F 1 0 0 0 NEG NEG NEG
20 1579/11 76 M 1 0 0 1 NEG NEG NEG
21 1580/11 36 F 2 0 0 0 NEG NEG NEG
22 1581/11 43 M 3 2 0 0 POS POS POS
23 1611/11 11 M 0 1 0 0 NEG NEG NEG
24 1612/11 44 M 2 0 0 1 POS POS POS
25 1613/11 38 M 2 1 1 2 POS POS POS
26 1614/11 45 F 1 0 0 0 NEG NEG NEG
27 1615/11 32 F 2 1 0 0 POS POS POS
28 1616/11 84 M 1 0 0 0 NEG NEG NEG
29 1660/11 24 M 1 0 0 0 NEG NEG NEG
30 1662/11 72 M 1 0 0 1 NEG NEG NEG
31 1666/11 54 F 2 1 0 1 POS POS POS
32 1667/11 62 F 3 2 1 2 POS POS POS
S.no  SYDNEY SCORING FOR GASTRITIS H.pylori-WS H.pylori-CF &LGSEXAGE Ref.no
CI ACTIVITY IM ATROPHY H.pylori S.no
 SYDNEY SCORING FOR GASTRITIS H.pylori-WS H.pylori-CF &LGSEXAGE Ref.no
33 1697/11 28 M 2 2 0 0 POS POS POS
34 1699/11 45 M 3 0 0 3 NEG NEG NEG
35 1701/11 23 M 0 1 0 0 NEG NEG NEG
36 1742/11 52 M 2 1 0 1 POS POS POS
37 1745/11 68 M 1 0 1 1 NEG NEG NEG
38 1746/11 39 F 3 2 0 0 POS POS POS
39 1747/11 46 F 1 0 0 1 POS NEG POS
40 1748/11 44 M 2 2 0 0 POS POS POS
41 1749/11 62 M 3 1 1 1 POS POS POS
42 1750/11 69 F 1 0 0 1 NEG NEG NEG
43 1764/11 74 M 2 1 1 1 POS POS POS
44 1802/11 40 M 3 0 0 1 NEG NEG NEG
45 1805/11 33 M 2 0 1 1 POS POS POS
46 1807/11 44 F 1 0 0 0 NEG NEG NEG
47 1808/11 62 M 2 0 0 1 NEG NEG NEG
48 1838/11 38 M 2 1 0 0 POS POS POS
49 1839/11 24 M 2 1 0 0 POS NEG POS
50 1840/11 24 M 1 0 0 0 NEG NEG NEG
51 1841/11 36 M 2 0 1 1 POS POS POS
52 3764/12 23 F 2 1 1 0 POS POS NEG
53 3765/12 48 F 2 3 0 0 POS POS POS
54 3766/12 25 M 0 1 0 0 NEG NEG NEG
55 3767/12 25 M 3 1 1 0 POS POS POS
56 3768/12 22 M 2 2 0 0 POS NEG POS
57 3769/12 24 M 1 0 0 0 NEG NEG NEG
58 3770/12 30 F 3 1 0 0 POS POS POS
59 3808/12 23 M 0 0 1 0 NEG NEG NEG
60 3810/12 27 M 2 1 0 0 POS POS POS
61 3812/12 16 F 0 1 0 0 NEG NEG NEG
62 3833/12 68 M 1 1 0 2 POS POS POS
63 3834/12 33 F 1 0 0 0 NEG NEG NEG
64 3835/12 41 F 0 1 0 0 NEG NEG NEG
CI ACTIVITY IM ATROPHY H.pylori S.no
 SYDNEY SCORING FOR GASTRITIS H.pylori-WS H.pylori-CF &LGSEXAGE Ref.no
65 3836/12 44 F 1 1 0 0 POS POS POS
66 3857/12 32 M 2 2 1 0 POS POS POS
67 3858/12 29 M 0 0 2 0 NEG NEG NEG
68 3860/12 27 M 2 2 1 0 POS POS NEG
69 4648/12 42 F 1 2 1 0 POS POS POS
70 4649/12 34 M 1 0 1 0 NEG NEG NEG
71 4651/12 52 M 1 2 0 2 POS NEG POS
72 7117/12 37 F 2 1 0 0 POS NEG POS
73 7118/12 27 F 2 1 0 0 POS POS POS
74 7120/12 42 M 2 3 0 0 POS POS POS
75 7144/12 29 F 2 0 0 0 NEG NEG NEG
76 7150/12 18 F 2 1 0 0 POS NEG POS
77 7151/12 52 M 2 1 0 0 POS POS NEG
78 7152/12 42 M 2 1 0 0 POS POS POS
79 7153/12 74 M 2 1 0 2 POS POS POS
80 7185/12 24 M 2 0 0 0 NEG NEG NEG
81 7186/12 31 F 2 2 0 0 POS POS POS
82 7187/12 38 M 2 2 0 0 POS POS POS
83 7268/12 63 M 2 2 0 2 POS POS POS
84 7271/12 39 F 2 3 0 0 POS POS POS
85 7272/12 53 M 2 3 0 0 POS POS POS
86 7347/12 32 M 0 1 0 0 NEG NEG NEG
87 7348/12 76 M 2 1 0 2 POS POS POS
88 7374/12 72 M 2 2 0 1 POS POS POS
89 7375/12 42 M 2 2 0 0 POS POS POS
90 7376/12 38 M 2 3 0 0 POS POS POS
91 7377/12 42 F 3 2 0 0 POS POS POS
92 7511/12 17 M 1 0 0 0 NEG NEG NEG
93 7512/12 11 M 0 1 0 0 NEG NEG NEG
94 7518/12 38 M 1 1 0 0 NEG NEG NEG
95 7519/12 45 F 1 3 0 0 POS POS POS
96 7520/12 84 M 1 2 0 0 POS POS POS
CI ACTIVITY IM ATROPHY H.pylori S.no
 SYDNEY SCORING FOR GASTRITIS H.pylori-WS H.pylori-CF &LGSEXAGE Ref.no
97 7521/12 74 M 1 2 0 0 POS POS POS
98 7587/12 54 M 1 0 0 0 NEG NEG NEG
99 7588/12 54 M 1 1 1 0 POS POS POS
100 7589/12 66 M 2 3 0 1 POS POS POS
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APPENDIX 
DEPARTMENT OF PATHOLOGY, TIRUNELVELI MEDICAL 
COLLEGE, TIRUNELVELI 
PROFORMA 
 
NAME :                                                                                                 BIOPSY No. : 
AGE :                                                                                                     OP/IP No. : 
SEX :                                                                                                      DEPARTMENT : 
OCCUPATION : 
ADDRESS : 
1. CLINICAL DETAILS : 
a) CHIEF COMPLAINTS : 
b) PAST HISTORY : 
c) FAMILY HISTORY : 
d) PERSONAL HISTORY : 
e) GENERAL EXAMINATION : 
f) SYSTEMIC EXAMINATION : 
CVS : 
RS : 
CNS : 
PA : 
2. INVESTIGATIONS : 
a) ROUTINE : Haemoglobin, Total Leucocyte count 
b) UPPER GASTROINTESTINAL ENDOSCOPY: 
3. CLINICAL DIAGNOSIS : 
 
4. HISTOPATHOLOGICAL EXAMINATION : 
a) MACROSCOPY: 
b) MICROSCOPY: 
c) SPECIAL STAINS: 
5. HISTOPATHOLOGICAL DIAGNOSIS : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 KEY TO MASTER CHART 
M     -  Male 
F    -  Female 
1     -  Mild 
2    -  Moderate 
3                              -  Severe 
CF    -  Chronic  Inflammation 
IM    -  Intestinal metaplasia 
H.pylori    -  Helicobacter pylori 
POS                         -  Positive  
NEG    -  Negative 
WS                          - Warthin starry 
CF & LG                - Carbol fuchsin and light green 
 
 
 
